Citi's Jason Gursky explains why he is constructive on Boeing in the long term, and what the company needs to do to get to a ...

Analyst Gil Blum from Needham maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) and keeping the price target at ...

Citi reaffirmed its optimistic stance on Apple Inc. (NASDAQ:AAPL) shares, maintaining a Buy rating and a price target of $255 ...

American Airlines (AAL – Research Report), the Industrials sector company, was revisited by a Wall Street analyst today. Analyst Thomas ...

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

The number of notable insider purchases has slowed since the beginning of the year. Yet one huge buy in the past week stood ...

Staszak has a bullish outlook on chicken demand in emerging markets as well. Argus has a "buy" rating and $60 price target for PPC stock, which closed at $45.53 on Jan. 13. Sun Life Financial is a ...

Rated "hold" by Argus with limited 12-month upside. Argus maintains a five-year "buy" rating with no price target. Vertex Pharmaceuticals specializes in developing therapies to treat cystic ...

CDNS stock currently trades at around $234 and analysts hold a consensus price target of $253.34 for the stock with a Buy rating. Its software niche and innovation have helped Cadence maintain its ...